Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: 16 - The Untold Story

Palantir’s Stellar Rise: How High Can PLTR Stock Go in 2025?

The Street-high target suggests further upside in Palantir stock from current levels, indicating room for further gains.

Barchart

Palantir Scores First $1 Billion Contract; Is It Priced In?

Palantir's first $1 billion contract is the latest example of how the company has managed to silence its naysayers, but may be priced into PLTR stock

MarketBeat

Wedbush Is Doubling Down on Palantir Stock Amid a ‘Tidal Wave’ of Spending. Should You Buy PLTR Stock Now?

Palantir shares inched up Friday on an extended contract with the U.S. Army. Wedbush reiterates Palantir stock as ‘one of the best names to own’ in 2025.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Palantir: AI Leadership and Rising Analyst Expectations

A new price target from Bank of America raises the floor for Palantir stock, even as Institutional investment is still catching up to the price targets

MarketBeat

Here Are the Top 5 Best-Performing Stocks in the S&P 500 So Far This Year

This article highlights the five best-performing S&P 500 stocks of the year so far.

Barchart

Palantir’s Meteoric Rise Continues: Will PLTR Stock Double in 2025?

The company’s ability to grow revenue, expand margins, and deepen client relationships is helping to justify investor enthusiasm, which can help it double in 2025.

Barchart

Is Palantir Stock a Buy at All-Time Highs?

Palantir stock has delivered market-thumping gains to shareholders over the past two years and trades at a premium valuation in May 2025. Is PLTR stock still a good buy?

Barchart

Read news from The Economist, FT, and more,
with one subscription

Palantir Just Surpassed Salesforce. Could CRM Stock Be a Better Buy Than PLTR?

Wall Street’s AI fever sends Palantir soaring past CRM. But when growth meets valuation reality, Salesforce stock may be the safer bet.

Barchart

Can Palantir Stock Hit $150 in 2025?

Palantir stock has delivered outsized gains to shareholders since its IPO in 2020. Can the tech stock continue to surge higher in 2025?

Barchart

Insider Heather Planishek Just Bought Palantir Stock in a Record First for PLTR. Should You Buy Shares Now?

Palantir stock printed a new all-time high following news of its first insider buy in history. Wedbush says PLTR could join the trillion-dollar club within a few years.

Barchart

Palantir Is Now a Top-10 Tech Company. Should You Buy Standout PLTR Stock Now?

Palantir stock has delivered market-thumping returns to shareholders in the past year. Is PLTR stock still a good buy or is it overvalued?

Barchart

Palantir’s Latest Deal Could Put a Freeze on Its Stock Price

An expanded partnership with ICE highlights one reason many investors object to owning PLTR stock, but the company's valuation may be a stronger headwind.

MarketBeat

Cathie Wood Just Dumped $97 Million in Palantir Stock. Should You Sell PLTR Too?

Palantir is a high-flying tech stock that trades at a lofty multiple in May 2025. Is PLTR stock still a good buy?

Barchart

Palantir Reported a Blockbuster Q1. Is It Too Late to Buy PLTR Stock?

The company has excellent long-term prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

How to Buy PLTR for a 17% Discount, or Achieve a 29% Annual Return

Yesterday, with PLTR trading at $110.48, the June 20 put option with a strike price of $95 was trading around $3.20. Traders selling this put would receive $320 in option premium.

Barchart

Wedbush Says Palantir Is Still a ‘Top Pick’ in 2025. Is It Too Late to Buy PLTR Stock?

Despite valuation risks, Wedbush sees Palantir as a top 2025 pick, betting on AIP’s edge amid defense budget cuts

Kiplinger

Stock Market Today: Stocks Slip for a Second Straight Day

Solid earnings but mixed guidance amid more tariff uncertainty have markets searching for direction.

Barchart

Should You Buy the Post-Earnings Dip in Palantir Stock?

Palantir stock tanked Tuesday even though the big data analytics firm topped estimates in its fiscal Q1. Wedbush says PLTR shares are worth buying on the post-earnings dip.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Palantir Stock Drops Despite Stellar Earnings: What's Next?

Despite a strong earnings report, Palantir's stock dropped over 9%, raising questions about the company's lofty valuation even with the impressive growth

Barchart

Why Palantir Stock Is a Risky Bet for the Rest of 2025

Palantir’s valuation metrics suggest investors have priced in a great deal of future growth, leaving little room for error.

Barchart

Palantir’s Valuation ‘Doesn’t Make Any Sense,” Warns Analysts. Should You Still Buy PLTR Stock Before May 5?

A Jefferies analyst says Palantir is a well-run company with strong fundamentals but its valuation does not make sense. Wall Street at large is bearish at PLTR shares at writing.

MarketBeat

Palantir Earnings: 1 Bullish Signal and 1 Area of Concern

Investors are waiting for Palantir to report earnings on May 5; here are two things that investors should focus on prior to the company's quarterly print

Barchart

Do Wall Street Analysts Like Palantir Technologies Stock?

Palantir Technologies has continued to outperform the broader market over the past years, yet analysts remain cautious about the stock's prospects.

Barchart

Analysts Warn of ‘Substantial Risks’ for Palantir Stock Ahead of May 5

Palantir is expected to double its per-share earnings to $0.08 in Q1. Still, a UBS analyst warns of downside risk in PLTR shares ahead of May 5.

Barchart

Palantir Is Teaming Up With Google in Bid to Win More Gov Contracts. How Should You Play PLTR Stock Here?

Palantir announced an extended partnership with Google to integrate its cloud infrastructure into its FedStart initiative. But are PLTR shares worth owning at current levels?

1 … 15 16 17 18

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.